The development of RAPTA compounds for the treatment of tumors

被引:403
作者
Murray, Benjamin S. [1 ]
Babak, Maria V. [2 ]
Hartinger, Christian G. [2 ]
Dyson, Paul J. [3 ]
机构
[1] Univ Hull, Dept Chem, Kingston Upon Hull HU6 7RX, N Humberside, England
[2] Univ Auckland, Sch Chem Sci, Auckland 1142, New Zealand
[3] Ecole Polytech Fed Lausanne, Inst Sci & Ingn Chim, CH-1015 Lausanne, Switzerland
关键词
RAPTA; Bioorganometallic chemistry; Cancer; Metastasis; Angiogenesis; ARENE RUTHENIUM COMPLEXES; METALLODRUG-PROTEIN INTERACTIONS; IN-VITRO; ANTICANCER COMPLEXES; METAL-COMPLEXES; PTA COMPLEXES; BREAST-CANCER; DNA-BINDING; RUTHENIUM(II)-ARENE COMPLEXES; ORGANOMETALLIC RUTHENIUM(II);
D O I
10.1016/j.ccr.2015.06.014
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Ruthenium(II)-arene RAPTA-type compounds have been extensively explored for their medicinal properties. Herein a comprehensive review of this class of compounds is provided. A discussion of the basic RAPTA structure is given together with the ways it has been modified to elucidate the key role of each part and to afford targeted derivatives. The various mechanistic studies conducted on RAPTA compounds are described and these are linked to the observed macroscopic biological properties. Ultimately, the review shows that certain RAPTA compounds display quite unique properties that point towards a clinical investigation. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:86 / 114
页数:29
相关论文
共 127 条
[1]   Platinum group antitumor chemistry: Design and development of new anticancer drugs complementary to cisplatin [J].
Abu-Surrah, AS ;
Kettunen, M .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (11) :1337-1357
[2]   Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity [J].
Adhireksan, Zenita ;
Davey, Gabriela E. ;
Campomanes, Pablo ;
Groessl, Michael ;
Clavel, Catherine M. ;
Yu, Haojie ;
Nazarov, Alexey A. ;
Yeo, Charmian Hui Fang ;
Ang, Wee Han ;
Droege, Peter ;
Rothlisberger, Ursula ;
Dyson, Paul J. ;
Davey, Curt A. .
NATURE COMMUNICATIONS, 2014, 5
[3]   Synthesis, catalytic properties and biological activity of new water soluble ruthenium cyclopentadienyl PTA complexes [(C5R5)RuCl(PTA)2] (R = H, Me; PTA=1,3,5-triaza-7-phosphaadamantane) [J].
Akbayeva, DN ;
Gonsalvi, L ;
Oberhauser, W ;
Peruzzini, M ;
Vizza, F ;
Brüggeller, P ;
Romerosa, A ;
Sava, G ;
Bergamo, A .
CHEMICAL COMMUNICATIONS, 2003, (02) :264-265
[4]   Synthesis and characterisation of some water soluble ruthenium(II)-arene complexes and an investigation of their antibiotic and antiviral properties [J].
Allardyce, CS ;
Dyson, PJ ;
Ellis, DJ ;
Salter, PA ;
Scopelliti, R .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2003, 668 (1-2) :35-42
[5]   [Ru(η6-p-cymene)Cl2(pta)] (pta=1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane):: a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells [J].
Allardyce, CS ;
Dyson, PJ ;
Ellis, DJ ;
Heath, SL .
CHEMICAL COMMUNICATIONS, 2001, (15) :1396-1397
[6]   Strategy to tether organometallic ruthenium-arene anticancer compounds to recombinant human serum albumin [J].
Ang, Wee Han ;
Daldini, Elisa ;
Juillerat-Jeanneret, Lucienne ;
Dyson, Paul J. .
INORGANIC CHEMISTRY, 2007, 46 (22) :9048-9050
[7]   Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis [J].
Ang, Wee Han ;
Daldini, Elisa ;
Scolaro, Claudine ;
Scopelliti, Rosario ;
Juillerat-Jeannerat, Lucienne ;
Dyson, Paul J. .
INORGANIC CHEMISTRY, 2006, 45 (22) :9006-9013
[8]   Rational Design of an Organometallic Glutathione Transferase Inhibitor [J].
Ang, Wee Han ;
Parker, Lorien J. ;
De Luca, Anastasia ;
Juillerat-Jeanneret, Lucienne ;
Morton, Craig J. ;
Lo Bello, Mario ;
Parker, Michael W. ;
Dyson, Paul J. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2009, 48 (21) :3854-3857
[9]   Transcription Inhibition by Organometallic Ruthenium-Arene Anticancer Complexes in Live Mammalian Cells [J].
Astarina, Astrid ;
Chow, Mun Juinn ;
Ang, Wee Han .
AUSTRALIAN JOURNAL OF CHEMISTRY, 2012, 65 (09) :1271-1276
[10]   Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action [J].
Babak, Maria V. ;
Meier, Samuel M. ;
Huber, Kilian V. M. ;
Reynisson, Johannes ;
Legin, Anton A. ;
Jakupec, Michael A. ;
Roller, Alexander ;
Stukalov, Alexey ;
Gridling, Manuela ;
Bennett, Keiryn L. ;
Colinge, Jacques ;
Berger, Walter ;
Dyson, Paul J. ;
Superti-Furga, Giulio ;
Keppler, Bernhard K. ;
Hartinger, Christian G. .
CHEMICAL SCIENCE, 2015, 6 (04) :2449-2456